US Approves New Weight-Loss Device for Obese People
US regulators on Wednesday approved a new kind of pacemaker-like device that aims to help people lose weight by stimulating a nerve that runs from the brain to the stomach. The Maestro Rechargeable System is the first device for weight loss approved by the US Food and Drug Administration in eight years. Christopher Ochner, an obesity and nutrition expert at The Mount Sinai Hospital in New York, said the device's approval is a "positive step." "The vagal nerve, on which this system is designed to impart electrical impulses, is quite important in regulating communication along the gut-brain axis," he said.
- Dr. Christopher Ochner, PhD, Assistant Professor, Pediatrics, Adolescent Medicine, Psychiatry, Icahn School of Medicine at Mount Sinai

Mount Sinai Establishes Steven S. Elbaum Family Center for Caregiving
May 20, 2025 View All Press Releases
Mount Sinai Surgeons Perform First Heart-Liver-Kidney Transplants in New York State
May 20, 2025 View All Press Releases
Mount Sinai Launches AI Small Molecule Drug Discovery Center
Apr 02, 2025 View All Press Releases